<VariationArchive RecordType="classified" VariationID="830982" VariationName="NC_000017.11:g.(?_35103244)_(35119613_?)del" VariationType="Deletion" Accession="VCV000830982" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-26" DateCreated="2020-04-15" MostRecentSubmission="2023-03-26">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="821037" VariationID="830982">
      <GeneList>
        <Gene Symbol="RAD51D" FullName="RAD51 paralog D" GeneID="5892" HGNC_ID="HGNC:9823" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="35092221" stop="35119860" display_start="35092221" display_stop="35119860" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="33426810" stop="33446887" display_start="33426810" display_stop="33446887" Strand="-" />
          </Location>
          <OMIM>602954</OMIM>
          <Haploinsufficiency last_evaluated="2019-10-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAD51D">Some evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-10-09" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=RAD51D">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000017.11:g.(?_35103244)_(35119613_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" innerStart="33430263" innerStop="33446632" display_start="33430263" display_stop="33446632" variantLength="16370" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.(?_33430263)_(33446632_?)del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.(?_33430263)_(33446632_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000017.11:g.(?_35103244)_(35119613_?)del AND Breast-ovarian cancer, familial, susceptibility to, 4" Accession="RCV001031578" Version="2">
        <ClassifiedConditionList TraitSetID="7625">
          <ClassifiedCondition DB="MedGen" ID="C3280345">Breast-ovarian cancer, familial, susceptibility to, 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2023-03-26">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21822267</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7625" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16581" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Breast-ovarian cancer, familial 4</ElementValue>
                <XRef ID="Breast-ovarian+cancer%2C+familial+4/7868" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Breast-ovarian cancer, familial, susceptibility to, 4</ElementValue>
                <XRef ID="MONDO:0013669" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BROVCA4</ElementValue>
                <XRef Type="MIM" ID="614291" DB="OMIM" />
              </Symbol>
              <XRef ID="145" DB="Orphanet" />
              <XRef ID="C3280345" DB="MedGen" />
              <XRef ID="MONDO:0013669" DB="MONDO" />
              <XRef Type="MIM" ID="614291" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2356138" SubmissionDate="2023-03-21" DateLastUpdated="2023-03-26" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="NM_002878.3_Deletion (Exons 1-8)|MedGen:C3280345" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194884" DateUpdated="2023-03-26" DateCreated="2020-04-15" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21822267</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 1-8 of the RAD51D gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RAD51D are known to be pathogenic (PMID: 21822267). This variant has not been reported in the literature in individuals affected with RAD51D-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="RAD51D" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.(?_33430263)_(33446632_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3280345" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2356138" TraitType="Disease" MappingType="XRef" MappingValue="C3280345" MappingRef="MedGen">
        <MedGen CUI="C3280345" Name="Breast-ovarian cancer, familial, susceptibility to, 4" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

